MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2

Table 1 The relationship between clinical parameters and miR-645 expression in primary gastric cardia adenocarcinoma

Clinical parameters	N (%)	Relatives expression (Mean ± SEM)	p-value
Age (years)
≥ 60	15 (50)	2.1286 ± 0.59201	0.568
<60	15 (50)	1.9571 ± 0.52402
Gender
Male	18 (60)	2.1111 ± 0.42783	0.462
Female	12 (40)	2.3333 ± 0.65328
Size
≥5	13 (43.3)	2.7385 ± 100128	0.004*
<5	17 (56.7)	1.8235 ± 1.52214
Histologic differentiation
Well (W)	15 (50)	2.138 ± 0.1866	0.9427
Poorly (P)	15 (50)	2.198 ± 0.1903
Lymphatic metastasis
Yes	12 (40)	2.4583 ± 0.77864	<0.001**
No	18 (60)	1.4944 ± 1.36273
TNM stage
Stage I/II	16 (53.3)	2.9125 ± 1.33660	<0.001**
Stage III/IV	14 (46.7)	1.4857 ± 0.73991

ISSN: 1471-2407